Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
Nanosonics Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The company disclosed that it had repurchased a total of 2,310,812 shares prior to the latest reporting day, and a further 95,816 shares on the previous day, as part of its daily buy-back activity.
The updated filing, dated 10 March 2026, follows the initial buy-back notification lodged in December 2025 and the most recent prior update on 9 March 2026. This regular reporting underscores the company’s continued execution of its capital management strategy through on-market repurchases, which can support earnings per share and signal confidence in the firm’s valuation to investors.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company listed on the ASX under the code NAN, with its primary securities being ordinary fully paid shares. The company operates in the healthcare sector, focusing on advanced disinfection solutions and related technologies for clinical and medical environments.
YTD Price Performance: -13.35%
Average Trading Volume: 535,678
Technical Sentiment Signal: Sell
Current Market Cap: A$1.04B
See more insights into NAN stock on TipRanks’ Stock Analysis page.